Paracetamol (325mg) + Ibuprofen (400mg) + Magnesium Trisilicate (100mg)
Paa Tablet is used for pain relief.
15 tablets in 1 strip
Medoz Pharmaceutical Pvt. Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Paa Tablet is to be taken with food.
Taking it with food or milk helps to avoid stomach upset.
Paa Tablet is a combination of three medicines: Ibuprofen, Paracetamol/Acetaminophen and Magnesium Trisilicate which relieve pain. Ibuprofen is a non-steroidal antiinflammatory drug (NSAID) and Paracetamol/Acetaminophen is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Magnesium Trisilicate is an inorganic salt which reduces the amount of acid in the stomach and prevents damage to the stomach lining caused by Ibuprofen.
Related Warnings
Taking Ibuprofen+Paracetamol/Acetaminophen+Magnesium Trisilicate with alcohol can cause liver damage.
Paa Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Paa Tablet during lactation. Please consult your doctor.
Paa Tablet does not usually affect your ability to drive.
Paa Tablet should be used with caution in patients with kidney disease. Dose adjustment of Paa Tablet may be needed. Please consult your doctor.
Use of Paa Tablet is not recommended in patients with severe kidney disease. Long term use of this medicine can affect the kidney function.
Paa Tablet should be used with caution in patients with liver disease. Dose adjustment of Paa Tablet may be needed. Please consult your doctor.
However, the use of Paa Tablet is not recommended in patients with severe liver disease and active liver disease.
